Author: Mariah Taylor

The first patient to receive purified CAR-T cells is home and doing well, Charleston, S.C.-based MUSC Hollings Cancer Center said.

Of all cancer cases in men in 2024, 48% are predicted to be prostate, lung and colon and rectum and 51% of all new cases in women are expected to be from breast, lung and colon and rectum cancers, researchers…

A "legendary" Houston oncologist has developed a novel cancer treatment that boasts a complete remission rate among patients of 50%, ABC7 reported Feb. 3.

Here are six cancer vaccines showing promise or in development since May 2023: 

Little Rock-based University of Arkansas for Medical Sciences reached its $30 million fundraising goal and is closer to becoming a national cancer institute.

Houston-based University of Texas MD Anderson Cancer Center is the first International Atomic Energy Agency Collaborating Centre in the United States focused on healthcare.

Alexandra Miller, MD, PhD, a neurologist and neuro-oncologist who specializes in brain tumors, was named chief of the neuro-oncology program and co-director of the Brain and Spine Tumor Center at New York City-based NYU Langone's Perlmutter Cancer Center.

Here are 95 oncologists and oncology leaders stepping into new roles in 2024:

Biotech company Orbis Health Solutions was approved to begin a phase 3 clinical trial of its melanoma vaccine, ABC News reported Jan. 20.

This is the first year since the COVID-19 pandemic began that hospitals must independently decide if and how to implement masking, and cancer centers across the country are taking different approaches.